{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:47:28Z","timestamp":1791557248932,"version":"4.3.4"},"reference-count":34,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>The Aspergilli of section Usti (group ustus) are represented by over 20 species, of which Aspergillus calidoustus is the most relevant human pathogen. Invasive aspergillosis (IA) caused by these fungi is rare but could represent an emerging issue among the expanding population of patients with long-term immunosuppression receiving antifungal prophylaxis. Clinicians should be aware of this unusual type of IA, which often exhibits distinct clinical features, such as an insidious and prolonged course and a high occurrence of extra-pulmonary manifestations, such as skin\/soft tissue or brain lesions. Moreover, these Aspergillus spp. pose a therapeutic challenge because of their decreased susceptibility to azole drugs. In this review, we outline the microbiological and clinical characteristics of IA due to Aspergillus spp. of section Usti and discuss the therapeutic options.<\/jats:p>","DOI":"10.3390\/jof6020084","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T05:02:24Z","timestamp":1591938144000},"page":"84","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical Relevance and Characteristics of Aspergillus calidoustus and Other Aspergillus Species of Section Usti"],"prefix":"10.3390","volume":"6","author":[{"given":"Emmanouil","family":"Glampedakis","sequence":"first","affiliation":[{"name":"Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Erard","sequence":"additional","affiliation":[{"name":"Clinique de M\u00e9decine et sp\u00e9cialit\u00e9s, infectiologie, HFR-Fribourg, 1708 Fribourg, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Lamoth","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland"},{"name":"Institute of Microbiology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","article-title":"Invasive aspergillosis in patients with acute myeloid leukemia: A SEIFEM-2008 registry study","volume":"95","author":"Pagano","year":"2010","journal-title":"Haematologica"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/cid\/cix130","article-title":"Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis","volume":"64","author":"Lamoth","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3114\/sim.2011.69.06","article-title":"New taxa in Aspergillus section Usti","volume":"69","author":"Samson","year":"2011","journal-title":"Stud. Mycol."},{"key":"ref_7","first-page":"588","article-title":"Emerging pathogen Aspergillus calidoustus colonizes water distribution systems","volume":"49","author":"Hageskal","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1099\/ijs.0.041004-0","article-title":"Aspergillus baeticus sp. nov. and Aspergillus thesauricus sp. nov., two species in section Usti from Spanish caves","volume":"62","author":"Novakova","year":"2012","journal-title":"Int J. Syst. Evol. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.funbio.2012.06.001","article-title":"Identification of volatile markers for indoor fungal growth and chemotaxonomic classification of Aspergillus species","volume":"116","author":"Polizzi","year":"2012","journal-title":"Fungal Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archinte.1974.00320150160023","article-title":"Cure of Aspergillus ustus endocarditis on a prosthetic valve","volume":"133","author":"Carrizosa","year":"1974","journal-title":"Arch. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Glampedakis, E., Cassaing, S., Fekkar, A., Dannaoui, E., Bougnoux, M.E., Bretagne, S., Neofytos, D., Schreiber, P.W., Hennequin, C., and Morio, F. (2020). Invasive aspergillosis due to Aspergillus section Usti: A multicenter retrospective study. Clin. Infect. Dis.","DOI":"10.1093\/cid\/ciaa230"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Seroy, J., Antiporta, P., Grim, S.A., Proia, L.A., Singh, K., and Clark, N.M. (2017). Aspergillus calidoustus case series and review of the literature. Transpl. Infect. Dis., 19.","DOI":"10.1111\/tid.12755"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1099\/ijsem.0.001094","article-title":"Aspergillus asper sp. nov. and Aspergillus collinsii sp. nov., from Aspergillus section Usti","volume":"66","author":"Jurjevic","year":"2016","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/EC.00425-07","article-title":"Aspergillus calidoustus sp. nov., causative agent of human infections previously assigned to Aspergillus ustus","volume":"7","author":"Varga","year":"2008","journal-title":"Eukaryot. Cell"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ait-Ammar, N., Levesque, E., Murat, J.B., Imbert, S., Foulet, F., Dannaoui, E., and Botterel, F. (2018). Aspergillus pseudodeflectus: A new human pathogen in liver transplant patients. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3527-5"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/jcm.33.2.471-473.1995","article-title":"First reported case of Aspergillus granulosus infection in a cardiac transplant patient","volume":"33","author":"Fakih","year":"1995","journal-title":"J. Clin. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1128\/JCM.00588-09","article-title":"Cerebral aspergillosis caused by Aspergillus granulosus","volume":"47","author":"Sutton","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_18","unstructured":"Donnelly, J.P., Chen, S.C., Kauffman, C.A., Steinbach, W.J., Baddley, J.W., Verweij, P.E., Clancy, C.J., Wingard, J.R., Lockhart, S.R., and Groll, A.H. (2019). Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin. Infect. Dis., 46."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1128\/JCM.00825-16","article-title":"Evaluation of the Vitek MS Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry System for Identification of Clinically Relevant Filamentous Fungi","volume":"54","author":"McMullen","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3114\/sim.2007.59.12","article-title":"Polyphasic taxonomy of Aspergillus section Usti","volume":"59","author":"Houbraken","year":"2007","journal-title":"Stud. Mycol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/13693780902803040","article-title":"In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus","volume":"48","author":"Cuesta","year":"2010","journal-title":"Med. Mycol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e00244-18","DOI":"10.1128\/AAC.00244-18","article-title":"Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis","volume":"62","author":"Ghannoum","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/jac\/dky280","article-title":"Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species","volume":"73","author":"Wiederhold","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e01137-18","DOI":"10.1128\/AAC.01137-18","article-title":"Efficacy of Antifungal Monotherapies and Combinations against Aspergillus calidoustus","volume":"62","author":"Glampedakis","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1128\/JCM.01070-09","article-title":"Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network","volume":"47","author":"Balajee","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/TP.0b013e31825992f0","article-title":"Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis","volume":"94","author":"Egli","year":"2012","journal-title":"Transplantation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3201\/eid1203.050670","article-title":"Aspergillus ustus infections among transplant recipients","volume":"12","author":"Panackal","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_29","first-page":"399","article-title":"Successful Treatment of Invasive Fungal Infection Due to Highly Resistant Aspergillus calidoustus in an Allogeneic Hematopoietic Cell Transplant Recipient","volume":"185","author":"Mendoza","year":"2020","journal-title":"Mycopathologia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/jps.1132","article-title":"Tissue distribution of terbinafine in rats","volume":"90","author":"McLachlan","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1040841X.2018.1514366","article-title":"Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope((R))","volume":"45","author":"Seidel","year":"2019","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e01244-19","DOI":"10.1128\/AAC.01244-19","article-title":"Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients","volume":"63","author":"Lamoth","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/jac\/dkz078","article-title":"In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies","volume":"74","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/jac\/dkz022","article-title":"In vitro activity of APX001A against rare moulds using EUCAST and CLSI methodologies","volume":"74","year":"2019","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/6\/2\/84\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:38:13Z","timestamp":1760175493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/6\/2\/84"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["jof6020084"],"URL":"https:\/\/doi.org\/10.3390\/jof6020084","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,12]]}}}